{"symbol":"ABT","fiscalQuarter":"Q2-2014","reportDate":"2014-07-16","reportTime":"BMO","status":"reported","company":{"name":"Abbott Laboratories","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/ABT/earnings/Q2-2014","postBrief":{"headline":"Abbott Laboratories Beats on EPS, Stock Down 0.29%","keyNumbers":[{"metric":"EPS","actual":"$0.54","expected":"N/A","surprise":"+6.51%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Unknown","keyQuotes":[],"summary":"No transcript is on record, and the analysis is based solely on numerical results."},"guidanceChanges":{"summary":"No guidance data is available for this quarter.","changes":[]},"whatItMeans":"Abbott Laboratories reported an EPS of $0.54, which exceeded expectations by 6.51%. However, the stock reacted negatively, declining by 0.29%. The lack of revenue data and management commentary may have contributed to investor uncertainty.","metaDescription":"Abbott Laboratories (ABT) Q2 2014 earnings: EPS beat by 6.51%. Stock down 0.29%. Full breakdown."}}